Impact of Cystic Fibrosis and Kalydeco on Patient Reported Outcomes

• Research type

  Research Study

• Full title

  The Impact of Cystic Fibrosis and Kalydeco on Patient Reported Outcomes

• IRAS ID

  154743

• Contact name

  Gordon MacGregor

• Contact email

  gordon.macgregor@ggc.scot.nhs.uk

• Sponsor organisation

  Vertex Pharmaceuticals

• REC name

  South Central - Hampshire A Research Ethics Committee

• REC reference

  14/SC/0297

• Date of REC Opinion

  17 Jun 2014

• REC opinion

  Further Information Favourable Opinion